January 27, 2016—The Health Resources and Services Administration has postponed annual recertification of eligibility for most federal grantees in the 340B drug discount program, which had been scheduled to begin today. … [Read more...]
CMS Releases Long-Awaited Medicaid Drug Rebate Program Final Rule
So-called "AMP rule" has implications for 340B programJanuary 22, 2016—The Centers for Medicare & Medicaid Services has released a long-awaited final rule to implement the Affordable Care Act's Medicaid drug rebate provisions. … [Read more...]
Senate and House Committees Subpoena Pharma Executive Shkreli
Former Turing CEO reportedly invokes Fifth Amendment in response to Senate summonsJanuary 21, 2016—The House Oversight and Government Reform Committee has subpoenaed former Turing Pharmaceuticals chief executive Martin Shkreli to testify at a Jan. 26 hearing. Shkreli, meanwhile, has invoked the Fifth Amendment in response to a separate Dec. 24 subpoena to produce documents issued by the Senate Select Committee on Aging. … [Read more...]
MedPAC Votes to Cut 340B Hospitals’ Medicare Part B Drug Reimbursement
Recommendation still has to be formally submitted to CongressJanuary 14, 2016—The Medicare Payment Advisory Commission voted 14-3 today to recommend that Congress reduce Medicare Part B drug reimbursement for 340B hospitals by 10 percent of average sales price, which would cut the amount a hospital saves on a Part B drug by about 30 percent put the savings into the Medicare-funded hospital uncompensated care pool distribute … [Read more...]
Hospitals Decry MedPAC Draft Recommendation on 340B
Vulnerable patients would suffer if Congress embraces proposed changesJanuary 14, 2016—Three hospital associations have expressed concerns to congressional Medicare advisers about a draft recommendation regarding the 340B program being voted on this morning. … [Read more...]
Congress Members Want NIH Action on Pharma “Price Gouging”
"Unreasonably priced" drugs challenging families and providersJanuary 12, 2016—Fifty Members of Congress are asking the National Institutes of Health to use its existing statutory authority "to respond to the soaring cost of pharmaceuticals." … [Read more...]
340B Recertification for Most Federal Grantees Begins Jan. 27
Title X centers and hospitals will recertify their eligibility separatelyJanuary 8, 2015—Annual recertification of eligibility for most federal grantees in the 340B drug discount program will begin on Jan. 27 and end on March 2. … [Read more...]